Founded in December 2013, Adjuvatis is specialized in the development, manufacturing and formulation of biodegradable particles, called i-Particles®. Developed by Dr Bernard Verrier and his CNRS team at the Institute of Biology and Chemistry Proteins (www.ibcp.fr ) this innovative technology has multiple applications. Our company’s key objective is to share the i-Particles® platform and help biopharmaceutical & diagnostic companies in:
Our laboratories are located in Lyon Gerland, one of the largest biotech hubs in France, close to Sanofi Pasteur, Merial or ENS Lyon.
The combination of safe-by-design and sustainable development concepts
i-Particles® are made from a biocompatible and biodegradable polymer. With sizes ranging from 150 nm to 300 nm, these particles are synthesized at Adjuvatis following a robust and eco-friendly process.
Highly versatile technology
i-Particles® have shown important adjuvant properties by eliciting a strong and specific immune response when formulated with several types of proteins.
Thanks to their protective properties, they enable to lower the antigen amount by 10 to 100 times, offering a potential alternative to the controversial mineral salt-based adjuvants.